Megaloblastic Anemia
- 24 January 1963
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 268 (4) , 201-203
- https://doi.org/10.1056/nejm196301242680409
Abstract
MEGALOBLASTIC anemia is the hematologic result of any of a variety of etiologic factors causing improper nucleoprotein synthesis.1 Of these factors by far the most common are deficiencies of vitamin B12 or folate or both. Such deficiencies account for at least 95 per cent of all patients with megaloblastic anemia. The remainder — less than 5 per cent — probably include a number who have inadequate utilization of vitamin B12 or of folic acid, or both, as seemed to be true, at least in part, in a patient with liver disease who had a slight hematologic response to . . .Keywords
This publication has 7 references indexed in Scilit:
- The Diagnosis and Treatment of Folic Acid DeficiencyMedical Clinics of North America, 1962
- Changes in serum vitamin B12 levels in patients with megaloblastic anaemia treated with folic acidJournal of Clinical Pathology, 1962
- The Effect of "Minute" and "Titrated" Amounts of Folic Acid on the Megaloblastic Anemia of Tropical SprueBlood, 1961
- Megaloblastic Anemia Associated with Inhibition of Thyrmine Synthesis (Observations During 5-fluorouracil Treatment)Blood, 1960
- Refractory Megaloblastic Anemia Associated with Excretion of Orotic AcidBlood, 1959